Mark Roskey
Chief Tech/Sci/R&D Officer at QUANTERIX CORPORATION
Net worth: 452 729 $ as of 31/03/2024
Profile
Mark T.
Roskey is currently the Chief Science & Collaboration Officer at Quanterix Corp.
He previously worked as the Marketing Director at Applied Biosystems, Inc. and as the SVP-Applied Biology Research & Development at Caliper Life Sciences, Inc. From 2011 to 2014, he was the Vice President & GM-LST Americas Sales & Services at Revvity, Inc. He also served as the Vice President-Worldwide Marketing at Zymark Corp.
from 2001 to 2003.
Dr. Roskey holds a doctorate degree from the University of Notre Dame and an undergraduate degree from Framingham State College.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
QUANTERIX CORPORATION
0.05% | 01/03/2023 | 19,216 ( 0.05% ) | 452 729 $ | 31/03/2024 |
Mark Roskey active positions
| Companies | Position | Start |
|---|---|---|
| QUANTERIX CORPORATION | Chief Tech/Sci/R&D Officer | - |
Former positions of Mark Roskey
| Companies | Position | End |
|---|---|---|
| REVVITY, INC. | Corporate Officer/Principal | 01/09/2014 |
Zymark Corp.
 Zymark Corp. Medical SpecialtiesHealth Technology Zymark is a provider of laboratory automation, liquid handling and robotics solutions to the life sciences, biotechnology and pharmaceutical industries. | Sales & Marketing | 01/08/2003 |
Applied Biosystems, Inc.
 Applied Biosystems, Inc. Medical SpecialtiesHealth Technology Applied Biosystems, Inc. is a company that provides integrated systems for sequencing, flow cytometry, and various types of PCR. The company is based in Foster City, CA. The company's products cover the entire process from sample preparation to data analysis. The company was founded by Chris Yoo, Marvin H. Caruthers, Michael W. Hunkapiller, and Leroy E. Hood. Applied Biosystems was acquired by Invitrogen Corp. from Applera Corp. on November 21, 2008 for $6,417.85 million. | Sales & Marketing | - |
Caliper Life Sciences, Inc.
 Caliper Life Sciences, Inc. SemiconductorsElectronic Technology Caliper Life Sciences, Inc. develops, manufactures, and sells labchip systems. It offers microfluids, lab automation, liquid handling, optical imaging technologies, and discovery and development outsourcing solutions. The company was founded by Michael R. Knapp on July 26, 1995 and is headquartered in Hopkinton, MA. | Chief Tech/Sci/R&D Officer | - |
Training of Mark Roskey
| University of Notre Dame | Doctorate Degree |
| Framingham State College | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| REVVITY, INC. | Health Technology |
| QUANTERIX CORPORATION | Health Technology |
| Private companies | 3 |
|---|---|
Caliper Life Sciences, Inc.
Caliper Life Sciences, Inc. SemiconductorsElectronic Technology Caliper Life Sciences, Inc. develops, manufactures, and sells labchip systems. It offers microfluids, lab automation, liquid handling, optical imaging technologies, and discovery and development outsourcing solutions. The company was founded by Michael R. Knapp on July 26, 1995 and is headquartered in Hopkinton, MA. | Electronic Technology |
Zymark Corp.
Zymark Corp. Medical SpecialtiesHealth Technology Zymark is a provider of laboratory automation, liquid handling and robotics solutions to the life sciences, biotechnology and pharmaceutical industries. | Health Technology |
Applied Biosystems, Inc.
Applied Biosystems, Inc. Medical SpecialtiesHealth Technology Applied Biosystems, Inc. is a company that provides integrated systems for sequencing, flow cytometry, and various types of PCR. The company is based in Foster City, CA. The company's products cover the entire process from sample preparation to data analysis. The company was founded by Chris Yoo, Marvin H. Caruthers, Michael W. Hunkapiller, and Leroy E. Hood. Applied Biosystems was acquired by Invitrogen Corp. from Applera Corp. on November 21, 2008 for $6,417.85 million. | Health Technology |
- Stock Market
- Insiders
- Mark Roskey
